Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Evaluate safety profiles of Sp 500 versus Total Stock Market funds for retirement, considering historically tracked volatility and resilience.
28,530 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
TeraWulf releases Q4 2025 results after the bell, signaling a shift from Bitcoin mining to AI compute. After-hours tr...
Quantum computing is moving from theory to real-world profit paths. This guide highlights two stocks and a practical ...
VW's 100,000-job layoff plan signals a broader shift in auto manufacturing. As Chinese EVs tighten market share, inve...
Microsoft’s latest earnings show a resilient AI-powered expansion, with a $627 billion backlog and a near $37 billion...
TSMC delivers a record quarterly print as AI-driven demand powers growth. Margin expands and 2026 guidance rises, sig...
As earnings season winds down, March can be a smart time to add leading tech stocks to your portfolio. Explore three ...
CrowdStrike is grabbing renewed attention on Wall Street after reporting record ARR growth and its first GAAP profit,...
AppLovin stock declines after fresh short-seller concerns about competition surface, even as Q4 numbers show strong c...
Nvidia is set to outline how it will deploy its cash as AI demand drives growth. The company still pays a token divid...
Home Depot faces a choppy housing backdrop even as demand proves resilient. This report weighs whether prediction: ho...